USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022
Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022
Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs
06-Jun-2018
Global
Description
Globally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of treatment in cases of CHF, hypertension, and diabetes, obesity treatment requires a mixture of nutritional, behavioral, and drug therapies, wherein drugs act as an adjunct to the behavioral therapies.
With the growing number of cardiometabolic cases worldwide, the market is slowly shifting toward ‘Therapy-as-a-Service’ model, with the implementation of adjunct therapies such as digital therapeutics, AI-based predictive diagnostic tools as well as nutritional and behavioral therapies alongside traditional drug treatment. This has helped establish a comprehensive care continuum across the industry, with wellness programs playing an important role in disease diagnosis, treatment, and monitoring.
Research Scope
The present study aims at identifying some of the key growth opportunities, which are set to drive the market in the next few years. Additionally, the study also identifies the most prevalent and emerging business models across the market, which are supporting industry stakeholders in enhancing their geographic coverage in terms of patient outreach and address challenges of inadequate patient access. The study provides in-depth revenue and market analysis of 4 key markets, chronic heart failure (CHF), hypertension, diabetes, and obesity. The study also highlights some of the key market drivers and restraints that affect the growth. It gives an overview of the competitive environment providing brief insights on some of the game-changing participants across each segment that are working toward developing disruptive technologies and drugs, thus maintaining their growth trajectory. Focus is also given on some of the leading M&A activities impacting the market as well as present and future market trends that would shape the market.
Key Issues Addressed
- How is the market attractiveness for cardiometabolic therapeutics evolving over the years? What is the future market potential?
- What is the role played by primary and community care in management of cardiometabolic diseases?
- What are the current and future trends impacting the market growth? What are the emerging business models set to transform the market landscape?
- What are the key regulatory and pricing changes across the cardiometabolic market? How are these changes expected to affect the market in the long run?
- What are the major growth opportunities across the cardiometabolic diseases market? What kind of impact would these have on the market growth?
- What are the applications of emerging technologies and digital transformation on the overall market? How is it expected to impact the market in the next few years?
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Key Findings
Key Findings (continued)
Scope and Segmentation
Key Questions to be Answered
Market Engineering Measurements
Market Engineering Measurements (continued)
Market Engineering Measurements (continued)
Market Engineering Measurements (continued)
CEO’s Perspective
Big Market Themes
Executive Summary—3 Big Predictions
Market Segmentation
Key Trends and Impact on the Market
Cardiometabolic Diseases—Value Chain Analysis
Impact of Regulatory and Pricing Policies
VBP Models—Impact Analysis
Disruptive Market Participants
New Market Opportunities
New Market Opportunities (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Market Drivers
Drivers Explained
Drivers Explained (continued)
Market Restraints
Restraints Explained
Restraints Explained (continued)
Market Summary
Methodology and Forecast Assumptions
Revenue Forecast by Segment
Revenue Forecast Discussion
Key Segment Findings
Key Segment Findings (continued)
Key Segment Findings (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Global Market Share Analysis
Competitive Landscape—Pipeline Analysis
Key Companies to Watch
Key Segment Findings
Key Segment Findings (continued)
Key Segment Findings (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Global Market Share Analysis
Competitive Landscape—Pipeline Analysis
Key Companies to Watch
Key Segment Findings
Key Segment Findings (continued)
Key Segment Findings (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Global Market Share Analysis
Competitive Landscape—Pipeline Analysis
Key Companies to Watch
Key Segment Findings
Key Segment Findings (continued)
Key Segment Findings (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Global Market Share Analysis
Competitive Landscape—Pipeline Analysis
Key Companies to Watch
Key Future Trends for Cardiometabolic Diseases Market
Transformation in Cardiometabolic Industry Ecosystem—2017
5 Major Growth Opportunities
Growth Opportunity Impact Analysis
Growth Opportunity 1—Enhanced Patient Engagement Through Digital Therapeutics
Growth Opportunity 2—Clinical Support leveraged Through AI
Growth Opportunity 3—Innovative Drug Delivery Technologies for Better Drug Efficacy
Growth Opportunity 4—Regenerative Medicine for Novel Curative Therapies
Growth Opportunity 5—Leveraging Biomarkers for Risk Assessment and Disease Diagnosis
Strategic Imperatives for Success and Growth
3 Big Predictions
Legal Disclaimer
Cardiometabolic Health Congress (CMHC)
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Abbreviations
Market Engineering Methodology
Popular Topics
Research Scope
The present study aims at identifying some of the key growth opportunities, which are set to drive the market in the next few years. Additionally, the study also identifies the most prevalent and emerging business models across the market, which are supporting industry stakeholders in enhancing their geographic coverage in terms of patient outreach and address challenges of inadequate patient access. The study provides in-depth revenue and market analysis of 4 key markets, chronic heart failure (CHF), hypertension, diabetes, and obesity. The study also highlights some of the key market drivers and restraints that affect the growth. It gives an overview of the competitive environment providing brief insights on some of the game-changing participants across each segment that are working toward developing disruptive technologies and drugs, thus maintaining their growth trajectory.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Aarti Chitale |
| Industries | Healthcare |
| WIP Number | MDB6-01-00-00-00 |
| Keyword 1 | Cardiometabolic |
| Is Prebook | No |
| GPS Codes | 9600-B1,9611-B1 |